Abstract: Medical devices including occlusive implants are disclosed. An example occlusive implant includes a proximal hub and an expandable framework including a plurality of struts spaced around a central longitudinal axis of the occlusive implant and forming a proximal region. Further, the plurality of the struts forming the proximal region includes a first row of struts, wherein the first row of struts includes between 18 and 68 struts. Further, the plurality of the struts forming the proximal region includes a second row of struts, wherein the second row of struts includes between 36 and 68 struts. Further, the proximal region includes a row of first connecting nodes coupled to both the first row of struts and the second row of struts. Further, at least one node of the row of first connecting nodes includes an extrados region, an intrados region or both an extrados region and an intrados region.

Abstract: Medical devices including occlusive implants are disclosed. An example occlusive implant includes a distal hub, a proximal hub and an expandable framework including a plurality of struts spaced around a central longitudinal axis and forming a distal region, a proximal region and an engagement region positioned between the distal region and the proximal region. The proximal region includes a proximal first row of struts coupled to a row of first connecting nodes. The proximal first row of struts includes between 18 and 68 struts. The distal region includes a distal first row of struts coupled to a row of second connecting nodes. The distal first row of struts includes between 9 and 68 struts. The engagement region includes between 18 and 34 struts. Further, at least one node of the row of first connecting nodes includes an extrados region, an intrados region or both an extrados region and intrados region.

Abstract: Medical devices including occlusive implants are disclosed. An example occlusive implant includes a distal hub and an expandable framework including a plurality of struts spaced around a central longitudinal axis of the occlusive implant and forming a distal region. The plurality of the struts forming the distal region includes a first row of struts, and wherein the first row of struts includes between 9 and 68 struts. The plurality of the struts forming the distal region includes a second row of struts, and wherein the second row of struts includes between 18 and 68 struts. The distal region includes a row of first connecting nodes coupled to both the first row of struts and the second row of struts. Further, at least one node of the row of first connecting nodes includes an extrados region, an intrados region or both an extrados region and an intrados region.

Abstract: An IS-4 terminal connector assembly includes three terminal electrodes positioned over an inner tubular member such that they are radially offset from one another. Each of the terminal ring electrodes are configured such that they can withstand both tensile and cyclical bending loads with minimal compromise in their outer geometry. Additionally, each of the terminal electrodes is configured such that they have both an inner and outer geometry that facilitates adequate insulation between a select terminal electrode and an adjacent conductor. Additionally, each of the terminal ring electrodes is configured such that they facilitate an external approach to staking a cable conductor.

Abstract: An active fixation lead may have a lead body formed at least in part from an inner member and an outer sheath. The inner member may include a pace/sense lumen and one or more cable lumens. The inner member may include one or more longitudinally extending crumple zones that are configured to reduce stress within the pace/sense lumen that could otherwise be caused by compressive forces applied to the lead.

Abstract: An active fixation lead may have a lead body formed at least in part from an inner member and an outer sheath. The inner member may include a pace/sense lumen and one or more cable lumens. The inner member may include one or more longitudinally extending crumple zones that are configured to reduce stress within the pace/sense lumen that could otherwise be caused by compressive forces applied to the lead.

Abstract: An IS-4 terminal connector assembly includes three terminal electrodes positioned over an inner tubular member such that they are radially offset from one another. Each of the terminal ring electrodes are configured such that they can withstand both tensile and cyclical bending loads with minimal compromise in their outer geometry. Additionally, each of the terminal electrodes is configured such that they have both an inner and outer geometry that facilitates adequate insulation between a select terminal electrode and an adjacent conductor. Additionally, each of the terminal ring electrodes is configured such that they facilitate an external approach to staking a cable conductor.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A valve for use in a body lumen, where the valve includes a valve leaflet with delayed leaflet deployment relative an in vivo implant time. The valve includes a valve frame, a valve leaflet coupled to the valve frame. The valve leaflet includes a commissure that can reversibly seal for unidirectional flow of a liquid through the valve, and a biodegradable adhesive between the valve leaflet and the valve frame to hold at least the commissure of the valve leaflet in a static relationship relative the valve frame for a predetermined time once implanted in vivo.

Abstract: A method of operating a double deck elevator system when the trailing elevator deck (26,28) is empty, whereby the leading deck answers all registered hall calls except upon the occurrence of certain conditions.

Abstract: An elevator system having a double-deck car (24) normally responds to unanswered up hall calls from intermediate floors with the upper deck (26), except, under one or more conditions, whereby a subsequent stop may be avoided, its lower deck (28) is utilized.

Abstract: A hitch assembly is disclosed for an elevator car suspended by hoist ropes and driven by a drive sheave. The hitch assembly having a hitch plate with openings for thimble rods, wherein geometrical planes bisecting the openings for the thimble rods are substantially coplanar with geometrical planes bisecting hoist rope grooved recesses in the drive sheave. Another feature of the present invention is a vibration isolation assembly for fastening the hitch plate to a mounting plate fixed to the elevator car, wherein the vibration isolation assembly isolates vibrations transmitted to the elevator car from the hoist ropes. Still another feature of the hitch assembly is a rope tension equalization assembly for fastening the hoist ropes to the hitch plate, wherein the rope tension equalization assembly equalizes tensions among the hoist ropes.

Abstract: An automated arrangement selects one of a plurality of load weight bypass thresholds for an elevator car. The selection depends, for example, upon the car direction and the time of day. Alternative embodiments of the arrangement utilize in the selection either actual or estimated elevator car floor space. Fuzzy logic is used to estimate available floor space.